Digital PCR (dPCR) and Real-time PCR (qPCR) Market Trend, Share, Growth, Size, Analysis and Forecast 2032

The global Digital PCR (dPCR) and Real-time PCR (qPCR) market size accrued earnings worth approximately USD 7.98 Billion in 2023 and is predicted to gain revenue of about USD 12.28 Billion by 2032, is set to record a CAGR of nearly 4.9% over the period from 2024 to 2032.

Request Free Sample

The report covers in-depth analysis of the strategies adopted by major competitors in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market. To understand the competitive landscape in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market, an analysis of Porter’s Five Forces model is also included. The research study comprises of market attractiveness analysis, wherein all the segments are benchmarked on the basis of their market size and growth rate.

Request Free Sample

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Scope

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation Analysis

The research study provides a decisive view on the global Digital PCR (dPCR) and Real-time PCR (qPCR) market based on Source, Packaging Process, Raw Material, End-Use, and Region. All the segments of the market have been analyzed based on the past, present, and future trends. The market is estimated from 2023 to 2032.

The nonstop technological innovations in PCR tools and increasing prevalence of target genetic disorders & infectious diseases are the primary factors anticipated to bolster the global Digital PCR (dPCR) and Real-time PCR (qPCR) market during the forecast period. Additionally, the increasing grants, investments, and funds will further help the market propel in the coming years. The mounting application of biomarker profiling for ailment diagnostics and efficacious accomplishment of the Human Genome Project is expected to fuel the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) market. The growing advancements in the R&D activities are projected to surge the demand for innovative Digital PCR (dPCR) and Real-time PCR (qPCR) techniques.

The proven effectiveness of dPCR and qPCR analysis in the estimation and diagnosis of disease-causing microbes will escalate the application of clinical diagnostic tests such as qPCR and dPCR analysis, thereby augmenting the market growth.  The high costs of the instruments, especially dPCR, and the technical limitations of PCR are likely to restrain the market growth. Furthermore, the large capital investments and intricate scientific validation on a nanoscale level during the development of qPCR and dPCR instruments coupled with the demand for specific reagents depending on the end-use will hamper the Digital PCR (dPCR) and Real-time PCR (qPCR) market growth.

On the basis of product & services, the global Digital PCR (dPCR) and Real-time PCR (qPCR) market is divided into Instruments, Reagents & Consumables, and Software & Services. Based on application, the market for Digital PCR (dPCR) and Real-time PCR (qPCR) is segregated into Clinical, Research, and Forensics. In terms of end-user, the market is categorized into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories.

The regional segmentation comprises the past, present, and estimated demand for the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. The regional segment is further split into the U.S., Canada, Mexico, UK, France, Germany, China, Japan, India, South Korea, Brazil, and Argentina among others.

Some of the key players,

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Qiagen
• Takara
• Agilent
• Danaher
• Abbott
• Merck
• Becton Dickinsonand QIAGEN N.V.

The report categorizes the global Digital PCR (dPCR) and Real-time PCR (qPCR) market into:

By Products & Services Segments

• Instruments
• Reagents & Consumables
• Software & Services

By Application Segments

• Clinical

  • Infectious Diseases Testing
  • Oncology Testing
  • Blood Screening
  • Transplant Diagnostics
  • Others
• Research
• Forensic

By End-User Segments

• Hospitals and Diagnostic Centers
• Research Laboratories and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

By Regional Segments

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa